Back to RXRX
SOFTBANK GROUP CORP. RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
4
Latest value
$56.3M
Q3 2026
Peak value
$56.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $55.8M |
| Q1 2026 | $41.9M |
| Q2 2026 | $50M |
| Q3 2026 | $56.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $56.3M | 13.64M | — | — |
| Q2 2026 | $50M | 13.64M | — | — |
| Q1 2026 | $41.9M | 13.64M | — | — |
| Q4 2025 | $55.8M | 13.64M | — | — |